These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23100517)

  • 21. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.
    Vincent IE; Zannetti C; Lucifora J; Norder H; Protzer U; Hainaut P; Zoulim F; Tommasino M; Trépo C; Hasan U; Chemin I
    PLoS One; 2011; 6(10):e26315. PubMed ID: 22046272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.
    Butterfield JSS; Biswas M; Shirley JL; Kumar SRP; Sherman A; Terhorst C; Ling C; Herzog RW
    Hum Gene Ther Methods; 2019 Jun; 30(3):81-92. PubMed ID: 31140323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished secretion and function of IL-29 is associated with impaired IFN-α response of neonatal plasmacytoid dendritic cells.
    Wisgrill L; Wessely I; Netzl A; Pummer L; Sadeghi K; Spittler A; Berger A; Förster-Waldl E
    J Leukoc Biol; 2019 Nov; 106(5):1177-1185. PubMed ID: 31211458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection.
    Kader M; Smith AP; Guiducci C; Wonderlich ER; Normolle D; Watkins SC; Barrat FJ; Barratt-Boyes SM
    PLoS Pathog; 2013; 9(7):e1003530. PubMed ID: 23935491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II.
    Benitez-Ribas D; Tacken P; Punt CJ; de Vries IJ; Figdor CG
    J Immunol; 2008 Oct; 181(8):5219-24. PubMed ID: 18832675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of human B cell activation by TLR7 and TLR9 agonists.
    Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
    BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells.
    Varani S; Cederarv M; Feld S; Tammik C; Frascaroli G; Landini MP; Söderberg-Nauclér C
    J Immunol; 2007 Dec; 179(11):7767-76. PubMed ID: 18025223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
    J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation.
    Stout-Delgado HW; Yang X; Walker WE; Tesar BM; Goldstein DR
    J Immunol; 2008 Nov; 181(10):6747-56. PubMed ID: 18981092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
    Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
    Front Immunol; 2018; 9():3070. PubMed ID: 30622542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG.
    Wu J; Li S; Li T; Lv X; Zhang M; Zang G; Qi C; Liu YJ; Xu L; Chen J
    J Immunol Res; 2019; 2019():1749803. PubMed ID: 31093508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
    Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
    J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis.
    Balashov KE; Aung LL; Vaknin-Dembinsky A; Dhib-Jalbut S; Weiner HL
    Ann Neurol; 2010 Dec; 68(6):899-906. PubMed ID: 21061396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.
    Cao W; Bover L; Cho M; Wen X; Hanabuchi S; Bao M; Rosen DB; Wang YH; Shaw JL; Du Q; Li C; Arai N; Yao Z; Lanier LL; Liu YJ
    J Exp Med; 2009 Jul; 206(7):1603-14. PubMed ID: 19564354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.
    Libri NA; Barker SJ; Rosenberg WM; Semper AE
    J Viral Hepat; 2009 May; 16(5):315-24. PubMed ID: 19243499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
    Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
    J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
    Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
    Front Immunol; 2018; 9():364. PubMed ID: 29535732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
    Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
    Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role for IKKβ in production of type 1 interferons by plasmacytoid dendritic cells.
    Pauls E; Shpiro N; Peggie M; Young ER; Sorcek RJ; Tan L; Choi HG; Cohen P
    J Biol Chem; 2012 Jun; 287(23):19216-28. PubMed ID: 22511786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.